BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 19358279)

  • 1. The VE-cadherin binding domain of fibrinogen induces endothelial barrier permeability and enhances transendothelial migration of malignant breast epithelial cells.
    Sahni A; Arévalo MT; Sahni SK; Simpson-Haidaris PJ
    Int J Cancer; 2009 Aug; 125(3):577-84. PubMed ID: 19358279
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrin α2β1 mediates tyrosine phosphorylation of vascular endothelial cadherin induced by invasive breast cancer cells.
    Haidari M; Zhang W; Caivano A; Chen Z; Ganjehei L; Mortazavi A; Stroud C; Woodside DG; Willerson JT; Dixon RA
    J Biol Chem; 2012 Sep; 287(39):32981-92. PubMed ID: 22833667
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The expression of VE-cadherin in breast cancer cells modulates cell dynamics as a function of tumor differentiation and promotes tumor-endothelial cell interactions.
    Rezaei M; Cao J; Friedrich K; Kemper B; Brendel O; Grosser M; Adrian M; Baretton G; Breier G; Schnittler HJ
    Histochem Cell Biol; 2018 Jan; 149(1):15-30. PubMed ID: 29143117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disruption of endothelial adherens junction by invasive breast cancer cells is mediated by reactive oxygen species and is attenuated by AHCC.
    Haidari M; Zhang W; Wakame K
    Life Sci; 2013 Dec; 93(25-26):994-1003. PubMed ID: 24211779
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human mesenchymal stem cells inhibit vascular permeability by modulating vascular endothelial cadherin/β-catenin signaling.
    Pati S; Khakoo AY; Zhao J; Jimenez F; Gerber MH; Harting M; Redell JB; Grill R; Matsuo Y; Guha S; Cox CS; Reitz MS; Holcomb JB; Dash PK
    Stem Cells Dev; 2011 Jan; 20(1):89-101. PubMed ID: 20446815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ADAM10 regulates endothelial permeability and T-Cell transmigration by proteolysis of vascular endothelial cadherin.
    Schulz B; Pruessmeyer J; Maretzky T; Ludwig A; Blobel CP; Saftig P; Reiss K
    Circ Res; 2008 May; 102(10):1192-201. PubMed ID: 18420943
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Influence of VE-Cadherin on Adhesion and Incorporation of Breast Cancer Cells into Vascular Endothelium.
    Brock T; Boudriot E; Klawitter A; Großer M; Nguyen TTP; Giebe S; Klapproth E; Temme A; El-Armouche A; Breier G
    Int J Mol Sci; 2021 Jun; 22(11):. PubMed ID: 34205118
    [TBL] [Abstract][Full Text] [Related]  

  • 8. VE-cadherin RGD motifs promote metastasis and constitute a potential therapeutic target in melanoma and breast cancers.
    Bartolomé RA; Torres S; Isern de Val S; Escudero-Paniagua B; Calviño E; Teixidó J; Casal JI
    Oncotarget; 2017 Jan; 8(1):215-227. PubMed ID: 27966446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. VE-cadherin and beta-catenin binding dynamics during histamine-induced endothelial hyperpermeability.
    Guo M; Breslin JW; Wu MH; Gottardi CJ; Yuan SY
    Am J Physiol Cell Physiol; 2008 Apr; 294(4):C977-84. PubMed ID: 18287330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chlamydia pneumoniae infection promotes monocyte transendothelial migration by increasing vascular endothelial cell permeability via the tyrosine phosphorylation of VE-cadherin.
    Liu J; Miao G; Wang B; Zheng N; Ma L; Chen X; Wang G; Zhao X; Zhang L; Zhang L
    Biochem Biophys Res Commun; 2018 Mar; 497(2):742-748. PubMed ID: 29462613
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transference of recombinant VE-cadherin cytoplasmic domain alters endothelial junctional integrity and porcine microvascular permeability.
    Guo M; Wu MH; Granger HJ; Yuan SY
    J Physiol; 2004 Jan; 554(Pt 1):78-88. PubMed ID: 14678493
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The presence of alpha-catenin in the VE-cadherin complex is required for efficient transendothelial migration of leukocytes.
    van Buul JD; van Alphen FP; Hordijk PL
    Int J Biol Sci; 2009 Nov; 5(7):695-705. PubMed ID: 19918298
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phosphorylation of VE-cadherin controls endothelial phenotypes via p120-catenin coupling and Rac1 activation.
    Hatanaka K; Simons M; Murakami M
    Am J Physiol Heart Circ Physiol; 2011 Jan; 300(1):H162-72. PubMed ID: 21037229
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CMTM3 (CKLF-Like Marvel Transmembrane Domain 3) Mediates Angiogenesis by Regulating Cell Surface Availability of VE-Cadherin in Endothelial Adherens Junctions.
    Chrifi I; Louzao-Martinez L; Brandt M; van Dijk CGM; Burgisser P; Zhu C; Kros JM; Duncker DJ; Cheng C
    Arterioscler Thromb Vasc Biol; 2017 Jun; 37(6):1098-1114. PubMed ID: 28428220
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Augmentation of endothelial cell monolayer permeability by hyperthermia but not tumor necrosis factor: evidence for disruption of vascular integrity via VE-cadherin down-regulation.
    Friedl J; Turner E; Alexander HR
    Int J Oncol; 2003 Sep; 23(3):611-6. PubMed ID: 12888895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endothelial cadherins in cancer.
    Breier G; Grosser M; Rezaei M
    Cell Tissue Res; 2014 Mar; 355(3):523-7. PubMed ID: 24619142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ionizing radiation increases the endothelial permeability and the transendothelial migration of tumor cells through ADAM10-activation and subsequent degradation of VE-cadherin.
    Kouam PN; Rezniczek GA; Adamietz IA; Bühler H
    BMC Cancer; 2019 Oct; 19(1):958. PubMed ID: 31619190
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction of fibrin(ogen) with the endothelial cell receptor VE-cadherin: localization of the fibrin-binding site within the third extracellular VE-cadherin domain.
    Yakovlev S; Medved L
    Biochemistry; 2009 Jun; 48(23):5171-9. PubMed ID: 19413351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interferon (IFN)-beta 1a and IFN-beta 1b block IFN-gamma-induced disintegration of endothelial junction integrity and barrier.
    Minagar A; Long A; Ma T; Jackson TH; Kelley RE; Ostanin DV; Sasaki M; Warren AC; Jawahar A; Cappell B; Alexander JS
    Endothelium; 2003; 10(6):299-307. PubMed ID: 14741845
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of Sox-9, ER81 and VE-cadherin in retinoic acid-mediated trans-differentiation of breast cancer cells.
    Endo Y; Deonauth K; Prahalad P; Hoxter B; Zhu Y; Byers SW
    PLoS One; 2008 Jul; 3(7):e2714. PubMed ID: 18628953
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.